Offspring Biosciences AB is a research and product development organization based in Södertälje, specializing in therapeutic antibody contract research organization (CRO) services. The company focuses on human tissue-based binding analysis, which is essential for understanding how potential therapeutic agents interact with biological targets. This expertise extends to target validation, a critical step in the drug development process, where the viability of specific biological targets is assessed for therapeutic intervention.
The organization aims to accelerate drug development processes by employing precision molecular pathology techniques. Offspring Biosciences offers tailored solutions that cater to the specific needs of its clients, ensuring comprehensive support from the discovery phase through to clinical success. With a proven track record in the pharmaceutical industry, the company provides valuable insights derived from human tissue analysis, which aids in hit and lead identification during drug development.